Noh Dong-Young, Roh Jae Kyung, Kim Yeul Hong, Yoshida Kazuhiro, Baba Hideo, Samson-Fernando Marie Cherry Lynn, Misra Sanjeev, Aziz Zeba, Umbas Rainy, P Singh Yogendra, Shu Kam Mok Tony, Yang Han-Kwang, Akaza Hideyuki
Seoul National University College of Medicine, Seoul, Korea.
Yonsei University College of Medicine, Seoul, Korea.
Cancer Res Treat. 2017 Apr;49(2):283-291. doi: 10.4143/crt.2017.090. Epub 2017 Mar 9.
The symposium on "Oncology Leadership in Asia" was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with International Cancer Conference. Given the increasing incidence of cancer in all countries and regions of Asia, regardless of developmental stage, and also in light of the recognized need for Asian countries to enhance collaboration in cancer prevention, research, treatment and follow-up, the symposium was held with the aim of bringing together oncology specialists from eight countries and regions in Asia to present the status in their own national context and discuss the key challenges and requirements in order to establish a greater Asian presence in the area of cancer control and research. The task of bringing together diverse countries and regions is made all the more urgent in that while Asia now accounts for more than half of all new cancer cases globally, clinical guidelines are based predominantly on practices adopted in Western countries, which may not be optimized for unique ethnic, pharmacogenomic and cultural characteristics in Asia. Recognizing the need for Asia to better gather information and data for the compilation of Asia-specific clinical guidelines, the participants discussed the current status in Asia in the national and regional contexts and identified future steps towards integrated and collaborative initiatives in Asia. A key outcome of the symposium was a proposal to combine and integrate the activities of existing pan-Asian societies, including the Asian Pacific Federation of Organizations for Cancer Research and Control (APFOCC) and Asian Clinical Oncology Society (ACOS). Further proposals included the expansion of pan-Asian society membership to include individuals and the essential need to encourage the participation of young researchers in order to ensure self-sustainability of cancer control efforts in the future.
“亚洲肿瘤学领导力”研讨会作为韩国癌症协会第42届年会与国际癌症会议官方议程的一部分举行。鉴于亚洲所有国家和地区(无论发展阶段如何)癌症发病率不断上升,同时也鉴于亚洲国家在癌症预防、研究、治疗和随访方面加强合作的公认需求,此次研讨会旨在汇聚亚洲八个国家和地区的肿瘤学专家,介绍各自国家的情况,并讨论关键挑战和要求,以便在癌症控制和研究领域增强亚洲的影响力。将不同国家和地区汇聚在一起的任务变得更加紧迫,因为尽管亚洲目前占全球所有新增癌症病例的一半以上,但临床指南主要基于西方国家采用的做法,而这些做法可能并未针对亚洲独特的种族、药物基因组学和文化特征进行优化。认识到亚洲需要更好地收集信息和数据以编制针对亚洲的临床指南,与会者讨论了亚洲在国家和地区层面的现状,并确定了亚洲综合与合作倡议的未来步骤。研讨会的一个关键成果是提议合并和整合现有泛亚协会的活动,包括亚太癌症研究与控制组织联合会(APFOCC)和亚洲临床肿瘤学会(ACOS)。进一步的提议包括扩大泛亚协会成员以纳入个人,以及鼓励年轻研究人员参与的迫切需求,以确保未来癌症控制工作的自我可持续性。